EUVIMEDEUVIMED entdecken
Crossref

Accelerating drug discovery process with genome editing technology from Tokushima

Hiromi Takahashi

Folia Pharmacologica Japonica · 2023

DOI: 10.1254/fpj.23015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Folia Pharmacologica Japonica, 2023. Verfasst von Hiromi Takahashi. Beteiligte Einrichtung: SetsuroTech Inc. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems. Die Arbeit nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingCRISPR-Cas SystemsAnimalsMiceCRISPR-Associated Protein 9ElectroporationElectroporation Therapies

Substanzen

CRISPR-Associated Protein 9

Autor:innen und Institutionen

  • SetsuroTech Inc.

Zitieren

APA

Takahashi, H. (2023). Accelerating drug discovery process with genome editing technology from Tokushima. Folia Pharmacologica Japonica. https://doi.org/10.1254/fpj.23015

Vancouver

Takahashi H. Accelerating drug discovery process with genome editing technology from Tokushima. Folia Pharmacologica Japonica. 2023. doi:10.1254/fpj.23015

BibTeX
@article{Takahashi2023,
  author = {Takahashi, Hiromi},
  title = {Accelerating drug discovery process with genome editing technology from Tokushima},
  journal = {Folia Pharmacologica Japonica},
  year = {2023},
  doi = {10.1254/fpj.23015}
}
Kostenlos starten →